Core Viewpoint - Shenzhen BGI Intelligent Manufacturing Co., Ltd. has won a bid for the Shanghai CDC biobank project, amounting to 50.5 million RMB, aimed at providing advanced storage and management systems to support disease prevention and precision medicine development [1][2]. Group 1: Project Details - The project is officially titled "Biobank Storage and Management Facilities for Shanghai CDC" and was announced on May 29, 2025 [2][3]. - The bid amount for the project is 50.5 million RMB, which translates to approximately 7.1 million USD [2][3]. - BGI Intelligent Manufacturing's subsidiary, BGI Intelligent Storage, will provide solutions including the "MGICLab-LT620Prem" for the project [3]. Group 2: Company Overview - BGI Intelligent Manufacturing (stock code: 688114) is a global leader in life science core tools, focusing on the development of gene sequencers, laboratory automation, and multi-omics technologies [4]. - The company's biobank product line emphasizes intelligence, automation, and high security, catering to storage needs across a full temperature range from -196°C to 4°C [4]. - BGI's solutions are widely applied in research, healthcare, agriculture, and genetic resource conservation [4].
5050万大单!华大智造中标上海市疾病预防控制中心项目